The role of endothelial dysfunction and oxidative stress in cerebrovascular diseases

References

• Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics – 2013 update: a report from the American Heart Association. Circulation. 2013;127(1):e6–e245.
   PubMed Web of Science ®Google Scholar
• Hankey GJ. Stroke in young adults: implications of the long-term prognosis. JAMA. 2013;309(11):1171–1172.
   PubMed Web of Science ®Google Scholar
• Roach ES, Golomb MR, Adams R, et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke. 2008;39(9):2644–2691.
   PubMed Web of Science ®Google Scholar
• Mohr JP, Albers GW, Amarenco P, et al. American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Etiology of stroke. Stroke. 1997;28(7):1501–1506.
   PubMed Web of Science ®Google Scholar
• Chandra A, Li WA, Stone CR, et al. The cerebral circulation and cerebrovascular disease I: anatomy. Brain Circ. 2017;3(2):45–56.
   PubMedGoogle Scholar
• Chandra A, Stone CR, Li WA, et al. The cerebral circulation and cerebrovascular disease II: pathogenesis of cerebrovascular disease. Brain Circ. 2017;3(2):57–65.
   PubMedGoogle Scholar
• Chandra A, Stone CR, Du X, et al. The cerebral circulation and cerebrovascular disease III: stroke. Brain Circ. 2017;3(2):66–77.
   PubMedGoogle Scholar
• Ciccone MM, Miniello V, Marchioli R, et al. Morphological and functional vascular changes induced by childhood obesity. Eur J Cardiovasc Prev Rehabil. 2011;18(6):831–835.
   PubMedGoogle Scholar
• Ciccone MM, Scicchitano P, Salerno C, et al. Aorta structural alterations in term neonates: the role of birth and maternal characteristics. BioMed Res Int. 2013;2013:459168.
   PubMedGoogle Scholar
• Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999;340(2):115–126.
   PubMed Web of Science ®Google Scholar
• Ciccone MM, Cortese F, Gesualdo M, et al. Dietary intake of carotenoids and their antioxidant and anti-inflammatory effects in cardiovascular care. Mediators Inflamm. 2013;2013:782137.
   PubMed Web of Science ®Google Scholar
• Sumpio BE, Riley JT, Dardik A. Cells in focus: endothelial cell. Int J Biochem Cell Biol. 2002;34(12):1508–1512.
   PubMed Web of Science ®Google Scholar
• Brunner H, Cockcroft JR, Deanfield J, et al. Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23(2):233–246.
   PubMed Web of Science ®Google Scholar
• Cosentino F, Rubattu S, Savoia C, et al. Endothelial dysfunction and stroke. J Cardiovasc Pharmacol. 2001;38:S75–S78.
   PubMed Web of Science ®Google Scholar
• Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation. 2005;111(3):363–368.
   PubMed Web of Science ®Google Scholar
• Rundek T, Hundle R, Ratchford E, et al. Endothelial dysfunction is associated with carotid plaque: a cross-sectional study from the population based Northern Manhattan Study. BMC Cardiovasc Disord. 2006;6:35.
   PubMedGoogle Scholar
• Fichtlscherer S, Breuer S, Zeiher AM. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the ‘vulnerable’ patient. Circulation. 2004;110(14):1926–1932.
   PubMed Web of Science ®Google Scholar
• Santos-García D, Blanco M, Serena J, et al. Impaired brachial flow-mediated dilation is a predictor of a new-onset vascular event after stroke. Cerebrovasc Dis. 2011;32(2):155–162.
   PubMed Web of Science ®Google Scholar
• Müller M, Voges M, Piepgras U, et al. Assessment of cerebral vasomotor reactivity by transcranial Doppler ultrasound and breath-holding. A comparison with acetazolamide as vasodilatory stimulus. Stroke. 1995;26(1):96–100.
   PubMed Web of Science ®Google Scholar
• Haussen DC, Katsnelson M, Rodriguez A, et al. Moderate correlation between breath-holding and CO(2) Inhalation/hyperventilation methods for transcranial Doppler evaluation of cerebral vasoreactivity. J Clin Ultrasound. 2012;40(9):554–558.
   PubMed Web of Science ®Google Scholar
• Portegies ML, de Bruijn RF, Hofman A, et al. Cerebral vasomotor reactivity and risk of mortality: the Rotterdam Study. Stroke. 2014;45(1):42–47.
   PubMed Web of Science ®Google Scholar
• Ju K, Zhong L, Ni X, et al. Cerebral vasomotor reactivity predicts the development of acute stroke in patients with internal carotid artery stenosis. Neurol Neurochir Pol. 2018;52(3):374–378.
   PubMed Web of Science ®Google Scholar
• Staszewski J, Skrobowska E, Piusińska-Macoch R, et al. Cerebral and extracerebral vasoreactivity in patients with different clinical manifestations of cerebral small-vessel disease: data from the significance of hemodynamic and hemostatic factors in the course of different manifestations of cerebral small-vessel disease study. J Ultrasound Med. 2019;38(4):975–987.
   PubMed Web of Science ®Google Scholar
• Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701.
   PubMed Web of Science ®Google Scholar
• Fu JH, Lu CZ, Hong Z, et al. Relationship between cerebral vasomotor reactivity and white matter lesions in elderly subjects without large artery occlusive disease. J Neuroimaging. 2006;16(2):120–125.
   PubMed Web of Science ®Google Scholar
• Faraci FM, Heistad DD. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev. 1998;78(1):53–97.
   PubMed Web of Science ®Google Scholar
• Abbott NJ, Rönnbäck L, Hansson E. Astrocyte-endothelial interactions at the blood–brain barrier. Nat Rev Neurosci. 2006;7(1):41–53.
   PubMed Web of Science ®Google Scholar
• Miyamoto N, Pham LD, Seo JH, et al. Crosstalk between cerebral endothelium and oligodendrocyte. Cell Mol Life Sci. 2014;71(6):1055–1066.
   PubMed Web of Science ®Google Scholar
• Hassan A, Hunt BJ, O’Sullivan M, et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain. 2003;126(2):424–432.
   PubMedGoogle Scholar
• Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115(10):1285–1295.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336(15):1066–1071.
   PubMed Web of Science ®Google Scholar
• Tsihlis ND, Oustwani CS, Vavra AK, et al. Nitric oxide inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by increasing the ubiquitination and degradation of UbcH10. Cell Biochem Biophys. 2011;60(1–2):89–97.
   PubMed Web of Science ®Google Scholar
• Stone KP, Kastin AJ, Pan W. NFκB is an unexpected major mediator of interleukin-15 signaling in cerebral endothelia. Cell Physiol Biochem. 2011;28(1):115–124.
   PubMedGoogle Scholar
• Himadri P, Kumari SS, Chitharanjan M, et al. Role of oxidative stress and inflammation in hypoxia-induced cerebral edema: a molecular approach. High Alt Med Biol. 2010;11(3):231–244.
   PubMed Web of Science ®Google Scholar
• Wenzel P, Kossmann S, Münzel T, et al. Redox regulation of cardiovascular inflammation – immunomodulatory function of mitochondrial and Nox-derived reactive oxygen and nitrogen species. Free Radic Biol Med. 2017;109:48–60.
   PubMed Web of Science ®Google Scholar
• Bustamante A, Simats A, Vilar-Bergua A, et al. Blood/brain biomarkers of inflammation after stroke and their association with outcome: from C-reactive protein to damage-associated molecular patterns. Neurotherapeutics. 2016;13(4):671–684.
   PubMed Web of Science ®Google Scholar
• Li SJ, Zhang YF, Ma SH, et al. The role of NLRP3 inflammasome in stroke and central poststroke pain. Med Baltimore. 2018;97(33):e11861.
   PubMed Web of Science ®Google Scholar
• Ismael S, Zhao L, Nasoohi S, et al. Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke. Sci Rep. 2018;8(1):5971.
   PubMedGoogle Scholar
• Gong Z, Pan J, Shen Q, et al. Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia/reperfusion injury. J Neuroinflamm. 2018;15(1):242.
   PubMedGoogle Scholar
• Shimada K, Crother TR, Karlin J, et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity. 2012;36(3):401–414.
   PubMed Web of Science ®Google Scholar
• Yamasaki K, Muto J, Taylor KR, et al. NLRP3/cryopyrin is necessaryfor interleukin-1beta (IL-1beta) release in response to hyaluronan, anendogenous trigger of inflammation in response to injury. J Biol Chem. 2009;284(19):12762–12771.
   PubMed Web of Science ®Google Scholar
• Shi X, Xie WL, Kong WW, et al. Expression of the NLRP3 inflammasome in carotid atherosclerosis. J Stroke Cerebrovasc Dis. 2015;24(11):2455–2466.
   PubMed Web of Science ®Google Scholar
• Huang JM, Hu J, Chen N, et al. Relationship between plasma high-mobility group box-1 levels and clinical outcomes of ischemicstroke. J Crit Care. 2013;28(5):792–797.
   PubMed Web of Science ®Google Scholar
• Sapojnikova N, Kartvelishvili T, Asatiani N, et al. Correlation betweenMMP-9 and extracellular cytokine HMGB1 in predictionof human ischemic stroke outcome. Biochim Biophys Acta. 2014;1842(9):1379–1384.
   PubMed Web of Science ®Google Scholar
• Sokół B, Woźniak A, Jankowski R, et al. HMGB1 level in cerebrospinal fluid as a marker of treatment outcome in patients withacute hydrocephalus following aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2015;24(8):1897–1904.
   PubMed Web of Science ®Google Scholar
• Mattson MP. Neuroprotective signal transduction: relevance to stroke. Neurosci Biobehav Rev. 1997;21(2):193–206.
   PubMed Web of Science ®Google Scholar
• Wakkach A, Cottrez F, Groux H. Can interleukin-10 be used as a true immunoregulatory cytokine? Eur Cytokine Netw. 2000;11(2):153–160.
   PubMed Web of Science ®Google Scholar
• Caligiuri G, Rudling M, Ollivier V, et al. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med. 2003;9(1–2):10–17.
   PubMed Web of Science ®Google Scholar
• Cruz Y, García EE, Gálvez JV, et al. Release of interleukin-10 and neurotrophic factors in the choroid plexus: possible inductors of neurogenesis following copolymer-1 immunization after cerebral ischemia. Neural Regen Res. 2018;13(10):1743–1752.
   PubMed Web of Science ®Google Scholar
• He W, Song H, Ding L, et al. Association between IL-10 gene polymorphisms and the risk of ischemic stroke in a Chinese population. Int J Clin Exp Pathol. 2015;8:13489–13494.
   PubMedGoogle Scholar
• Lagerstedt L, Egea-Guerrero JJ, Rodríguez-Rodríguez A, et al. Early measurement of interleukin-10 predicts the absence of CT scan lesions in mild traumatic brain injury. PLoS One. 2018;13(2):e0193278.
   PubMed Web of Science ®Google Scholar
• Tian Y, Sommerville LJ, Cuneo A, et al. Expression and suppressive effects of interleukin-19 on vascular smooth muscle cell pathophysiology and development of intimal hyperplasia. Am J Pathol. 2008;173(3):901–909.
   PubMed Web of Science ®Google Scholar
• Gabunia K, Ellison SP, Singh H, et al. Interleukin-19 (IL-19) induces heme oxygenase-1 (HO − 1) expression and decreases reactive oxygen species in human vascular smooth muscle cells. J Biol Chem. 2012;287(4):2477–2484.
   PubMed Web of Science ®Google Scholar
• Gisterå A, Robertson AL, Andersson J, et al. Transforming growth factor–β signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17–dependent pathway. Sci Transl Med. 2013;5(196):196ra100.
   PubMed Web of Science ®Google Scholar
• Kim JS, Yoon SS, Kim YH, et al. Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. Stroke. 1996;27(9):1553–1557.
   PubMed Web of Science ®Google Scholar
• Cipollone F, Fazia M, Mincione G, et al. Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. Stroke. 2004;35(10):2253–2257.
   PubMed Web of Science ®Google Scholar
• Gojova A, Brun V, Esposito B, et al. Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice. Blood. 2003;102(12):4052–4058.
   PubMed Web of Science ®Google Scholar
• Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res. 1995;77(5):863–868.
   PubMed Web of Science ®Google Scholar
• Shah PK, Falk E, Badimon JJ, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation. 1995;92(6):1565–1569.
   PubMed Web of Science ®Google Scholar
• Miller AM, Xu D, Asquith DL, et al. IL-33 reduces the development of atherosclerosis. J Exp Med. 2008;205(2):339–346.
   PubMed Web of Science ®Google Scholar
• Zhang SR, Piepke M, Chu HX, et al. IL-33 modulates inflammatory brain injury but exacerbates systemic immunosuppression following ischemic stroke. JCI Insight. 2018;3(18). [pii: 121560]
   Web of Science ®Google Scholar
• Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell. 2012;48(2):158–167.
   PubMed Web of Science ®Google Scholar
• Harrison R. Structure and function of xanthine oxidoreductase: where are we now? Free Radic Biol Med. 2002;33(6):774–797.
   PubMed Web of Science ®Google Scholar
• Nomura J, Busso N, Ives A, et al. Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice. Sci Rep. 2014;4:4554.
   PubMed Web of Science ®Google Scholar
• Schröder K, Vecchione C, Jung O, et al. Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Western-type diet. Free Radic Biol Med. 2006;41(9):1353–1360.
   PubMed Web of Science ®Google Scholar
• Kigawa Y, Miyazaki T, Lei XF, et al. Functional heterogeneity of nadph oxidases in atherosclerotic and aneurysmal diseases. J Atheroscler Thromb. 2017;24(1):1–13.
   PubMed Web of Science ®Google Scholar
• Shami A, Gonçalves I, Hultgårdh-Nilsson A. Collagen and related extracellular matrix proteins in atheroscleroticplaque development. Curr Opin Lipidol. 2014;25(5):394–399.
   PubMed Web of Science ®Google Scholar
• Matés JM, Pérez-Gómez C, Núñez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem. 1999;32(8):595–603.
   PubMed Web of Science ®Google Scholar
• McCall MR, Frei B. Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radic Biol Med. 1999;26(7–8):1034–1053.
   PubMed Web of Science ®Google Scholar
• Fukai T, Galis ZS, Meng XP, et al. Vascular expression of extracellular superoxide dismutase in atherosclerosis. J Clin Invest. 1998;101(10):2101–2111.
   PubMed Web of Science ®Google Scholar
• Fukai T, Siegfried MR, Ushio-Fukai M, et al. Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension. Circ Res. 1999;85(1):23–28.
   PubMed Web of Science ®Google Scholar
• Gongora MC, Qin Z, Laude K, et al. Role of extracellular superoxide dismutase in hypertension. Hypertension. 2006;48(3):473–481.
   PubMed Web of Science ®Google Scholar
• Didion SP, Ryan MJ, Baumbach GL, et al. Superoxide contributes to vascular dysfunction in mice that express human renin and angiotensinogen. Am J Physiol Heart Circ Physiol. 2002;283(4):H1569–H1576.
   PubMed Web of Science ®Google Scholar
• Iida S, Chu Y, Weiss RM, et al. Vascular effects of a common gene variant of extracellular superoxide dismutase in heart failure. Am J Physiol Heart Circ Physiol. 2006;291(2):H914–H920.
   PubMed Web of Science ®Google Scholar
• Jung O, Marklund SL, Geiger H, et al. Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice. Circ Res. 2003;93(7):622–629.
   PubMed Web of Science ®Google Scholar
• Jung O, Marklund SL, Xia N, et al. Inactivation of extracellular superoxide dismutase contributes to the development of high-volume hypertension. Arterioscler Thromb Vasc Biol. 2007;27(3):470–477.
   PubMed Web of Science ®Google Scholar
• Qin Z, Reszka KJ, Fukai T, et al. Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD. Transl Res. 2008;151(2):68–78.
   PubMed Web of Science ®Google Scholar
• Oppermann M, Balz V, Adams V, et al. Pharmacological induction of vascular extracellular superoxide dismutase expression in vivo. J Cell Mol Med. 2009;13(7):1271–1278.
   PubMed Web of Science ®Google Scholar
• Takapoo M, Chamseddine AH, Bhalla RC, et al. Glutathione peroxidase-deficient smooth muscle cells cause paracrine activation of normal smooth muscle cells via cyclophilin A. Vascul Pharmacol. 2011;55(5–6):143–148.
   PubMed Web of Science ®Google Scholar
• Lewis P, Stefanovic N, Pete J, et al. Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice. Circulation. 2007;115(16):2178–2187.
   PubMed Web of Science ®Google Scholar
• Sharma A, Yuen D, Huet O, et al. Lack of glutathione peroxidase-1 facilitates a pro-inflammatory and activated vascular endothelium. Vascul Pharmacol. 2016;79:32–42.
   PubMed Web of Science ®Google Scholar
• Yang H, Roberts LJ, Shi MJ, et al. Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E. Circ Res. 2004;95(11):1075–1081.
   PubMed Web of Science ®Google Scholar
• Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr. 2000;71(2):621S–629S.
   PubMed Web of Science ®Google Scholar
• Sosa V, Moliné T, Somoza R, et al. Oxidative stress and cancer: an overview. Ageing Res Rev. 2013;12(1):376–390.
   PubMed Web of Science ®Google Scholar
• Di Lisa F, Kaludercic N, Carpi A, et al. Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66(Shc) and monoamine oxidase. Basic Res Cardiol. 2009;104(2):131–139.
   PubMed Web of Science ®Google Scholar
• Nanetti L, Taffi R, Vignini A, et al. Reactive oxygen species plasmatic levels in ischemic stroke. Mol Cell Biochem. 2007;303(1–2):19–25.
   PubMed Web of Science ®Google Scholar
• Kehrer JP. Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol. 1993;23(1):21–48.
   PubMed Web of Science ®Google Scholar
• Victor VM, Rocha M, Solá E, et al. Oxidative stress, endothelial dysfunction and atherosclerosis. Curr Pharm Des. 2009;15(26):2988–3002.
   PubMed Web of Science ®Google Scholar
• Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6(7):508–519.
   PubMed Web of Science ®Google Scholar
• Nilsson J, Hansson GK. Autoimmunity in atherosclerosis: a protective response losing control? J Intern Med. 2008;263(5):464–478.
   PubMed Web of Science ®Google Scholar
• Frostegård J, Nilsson J, Haegerstrand A, et al. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci U S A. 1990;87(3):904–908.
   PubMed Web of Science ®Google Scholar
• Steinberg D., Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation. 1997;95(4):1062–1071.
   PubMed Web of Science ®Google Scholar
• Morel DW, Hessler JR, Chisolm GM. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res. 1983;24(8):1070–1076.
   PubMed Web of Science ®Google Scholar
• Huang Y, Mironova M, Lopes-Virella MF. Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells. Arterioscler Thromb Vasc Biol. 1999;19(11):2640–2647.
   PubMed Web of Science ®Google Scholar
• Liu B, Sidiropoulos A, Zhao B, et al. Oxidized LDL damages endothelial cell monolayer and promotes thrombocyte adhesion. Am J Hematol. 1998;57(4):341–343.
   PubMed Web of Science ®Google Scholar
• Chai YC, Binion DG, Macklis R, et al. Smooth muscle cell proliferation induced by oxidized LDL-borne lysophosphatidylcholine. Evidence for FGF-2 release from cells not extracellular matrix. Vasc Pharmacol. 2002;38:229–237.
   PubMed Web of Science ®Google Scholar
• Tamai O, Matsuoka H, Itabe H, et al. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation. 1997;95(1):76–82.
   PubMed Web of Science ®Google Scholar
• Galle J, Hansen-Hagge T, Wanner C, et al. Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis. 2006;185(2):219–226.
   PubMed Web of Science ®Google Scholar
• Thomas CE, Jackson RL, Ohlweiler DF, et al. Multiple lipid oxidation products in low density lipoproteins induce interleukin-1beta release from human blood mononuclear cells. J Lipid Res. 1994;35(3):417–427.
   PubMed Web of Science ®Google Scholar
• Mylonas C, Kouretas D. Lipid peroxidation and tissue damage. In Vivo. 1999;13(3):295–309.
   PubMed Web of Science ®Google Scholar
• Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med. 2009;47(5):469–484.
   PubMed Web of Science ®Google Scholar
• Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320(14):915–924.
   PubMed Web of Science ®Google Scholar
• Stiko A, Regnström J, Shah PK, et al. Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA synthesis. Arterioscler Thromb Vasc Biol. 1996;16(2):194–200.
   PubMed Web of Science ®Google Scholar
• Allen CL, Bayraktutan U. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke. 2009;4(6):461–470.
   PubMed Web of Science ®Google Scholar
• Guldiken B, Guldiken S, Turgut B, et al. The roles of oxidized low-density lipoprotein and interleukin-6 levels in acute atherothrombotic and lacunar ischemic stroke. Angiology. 2008;59(2):224–229.
   PubMed Web of Science ®Google Scholar
• Uno M, Harada M, Takimoto O, et al. Elevation of plasma oxidized LDL in acute stroke patients is associated with ischemic lesions depicted by DWI and predictive of infarct enlargement. Neurol Res. 2005;27(1):94–102.
   PubMed Web of Science ®Google Scholar
• Aygul R, Kotan D, Demirbas F, et al. Plasma oxidants and antioxidants in acute ischaemic stroke. J Int Med Res. 2006;34(4):413–418.
   PubMed Web of Science ®Google Scholar
• Pacher P, Nivorozhkin A, Szabó C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006;58(1):87–114.
   PubMed Web of Science ®Google Scholar
• Jian Liu K, Rosenberg GA. Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radic Biol Med. 2005;39(1):71–80.
   PubMed Web of Science ®Google Scholar
• Montaner J, Molina CA, Monasterio J, et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications afterthrombolysis in human stroke. Circulation. 2003;107(4):598–603.
   PubMed Web of Science ®Google Scholar
• Zhang XH, Lei H, Liu AJ, et al. Increased oxidative stress is responsible for severer cerebral infarction in stroke-prone spontaneously hypertensive rats. CNS Neurosci Ther. 2011;17(6):590–598.
   PubMed Web of Science ®Google Scholar
• Nakajima H, Kubo T, Ihara H, et al. Nuclear-translocated glyceraldehyde-3-phosphate dehydrogenase promotes poly(ADP-ribose) polymerase-1 activation during oxidative/nitrosative stress in stroke. J Biol Chem. 2015;290(23):14493–14503.
   PubMed Web of Science ®Google Scholar
• McCarty MF. NADPH oxidase activity in cerebral arterioles is a key mediator of cerebral small vessel disease-implications for prevention. Healthcare. 2015;3(2):233–251.
   Web of Science ®Google Scholar
• Adameova A, Xu YJ, Duhamel TA, et al. Anti-atherosclerotic molecules targeting oxidative stress and inflammation. Curr Pharm Des. 2009;15(27):3094–3107.
   PubMed Web of Science ®Google Scholar
• Scicchitano P, Cameli M, Maiello M, et al. Nutraceuticals and dyslipidaemia: beyond the common therapeutics. J Funct Foods. 2014;6:11–32.
   Web of Science ®Google Scholar
• Murad LB, Guimarães MR, Paganelli A, et al. Alpha-tocopherol in the brain tissue preservation of stroke-prone spontaneously hypertensive rats. J Physiol Biochem. 2014;70(1):49–60.
   PubMed Web of Science ®Google Scholar
• Song J, Park J, Kim JH, et al. Dehydroascorbic acid attenuates ischemic brain edema and neurotoxicity in cerebral ischemia: an in vivo study. Exp Neurobiol. 2015;24:41–54.
   PubMed Web of Science ®Google Scholar
• Cavdar Z, Egrilmez MY, Altun ZS, et al. Resveratrol reduces matrix metalloproteinase-2 activity induced by oxygen-glucose deprivation and reoxygenation in human cerebral microvascular endothelial cells. Int J Vitam Nutr Res. 2012;82(4):267–274.
   PubMed Web of Science ®Google Scholar
• He Q, Li S, Li L, et al. Total flavonoids in Caragana (TFC) promotes angiogenesis and enhances cerebral perfusion in a rat model of ischemic stroke. Front Neurosci. 2018;12:635.
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Kobara N, Higashino S, et al. Astaxanthin inhibits thrombosis in cerebral vessels of stroke-prone spontaneously hypertensive rats. Nutr Res. 2011;31(10):784–789.
   PubMed Web of Science ®Google Scholar
• Pan L, Zhou Y, Li XF, et al. Preventive treatment of astaxanthin provides neuroprotection through suppression of reactive oxygen species and activation of antioxidant defense pathway after stroke in rats. Brain Res Bull. 2017;130:211–220.
   PubMed Web of Science ®Google Scholar
• Belousova M, Tokareva OG, Gorodetskaya E, et al. Intravenous treatment with coenzyme Q10 improves neurological outcome and reduces infarct volume after transient focal brain ischemia in rats. J Cardiovasc Pharmacol. 2016;67(2):103–109.
   PubMed Web of Science ®Google Scholar
• Cheng P, Wang L, Ning S, et al. Vitamin E intake and risk of stroke: a meta-analysis. Br J Nutr. 2018;120(10):1181–1188.
   PubMed Web of Science ®Google Scholar
• Bin Q, Hu X, Cao Y, et al. The role of vitamin E (tocopherol) supplementation in the prevention of stroke. A meta-analysis of 13 randomised controlled trials. Thromb Haemost. 2011;105:579–585.
   PubMed Web of Science ®Google Scholar
• Schürks M, Glynn RJ, Rist PM, et al. Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ. 2010;341:c5702.
   PubMed Web of Science ®Google Scholar
• Kubota Y, Iso H, Date C, et al. Dietary intakes of antioxidant vitamins and mortality from cardiovascular disease: the Japan Collaborative Cohort Study (JACC) study. Stroke. 2011;42(6):1665–1672.
   PubMed Web of Science ®Google Scholar
• Chen GC, Lu DB, Pang Z, et al. Vitamin C intake, circulating vitamin C and risk of stroke: a meta-analysis of prospective studies. J Am Heart Assoc. 2013;2(6):e000329.
   PubMed Web of Science ®Google Scholar
• Mursu J, Voutilainen S, Nurmi T, et al. Flavonoid intake and the risk of ischaemic stroke and CVD mortality in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr. 2008;100(4):890–895.
   PubMed Web of Science ®Google Scholar
• Hollman PC, Geelen A, Kromhout D. Dietary flavonol intake may lower stroke risk in men and women. J Nutr. 2010;140(3):600–604.
   PubMed Web of Science ®Google Scholar
• Cassidy A, Rimm EB, O’Reilly EJ, et al. Dietary flavonoids and risk of stroke in women. Stroke. 2012;43(4):946–951.
   PubMed Web of Science ®Google Scholar
• Wang ZM, Zhao D, Nie ZL, et al. Flavonol intake and stroke risk: a meta-analysis of cohort studies. Nutrition. 2014;30(5):518–523.
   PubMed Web of Science ®Google Scholar
• Hirvonen T, Virtamo J, Korhonen P, et al. Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke. 2000;31(10):2301–2306.
   PubMed Web of Science ®Google Scholar
• Li X, Xu J. Dietary and circulating lycopene and stroke risk: a meta-analysis of prospective studies. Sci Rep. 2014;4:5031.
   PubMed Web of Science ®Google Scholar
• Daviglus ML, Orencia AJ, Dyer AR, et al. Dietary vitamin C, beta-carotene and 30-year risk of stroke: results from the Western Electric Study. Neuroepidemiology. 1997;16(2):69–77.
   PubMed Web of Science ®Google Scholar
• Simani L, Ryan F, Hashemifard S, et al. Serum coenzyme Q10 is associated with clinical neurological outcomes in acute stroke patients. J Mol Neurosci. 2018;66(1):53–58.
   PubMed Web of Science ®Google Scholar
• Ramezani M, Sahraei Z, Simani L, et al. Coenzyme Q10 supplementation in acute ischemic stroke: is it beneficial in short-term administration? Nutr Neurosci. 2018:1–6 doi: 10.1080/1028415X.2018.1541269.
   PubMedGoogle Scholar
• Devaraj S, Li D, Jialal I. The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1beta secretion, and monocyte adhesion to endothelium. J Clin Invest. 1996;98(3):756–763.
   PubMed Web of Science ®Google Scholar
• Ashor AW, Brown R, Keenan PD, et al. Limited evidence for a beneficial effect of vitamin C supplementation on biomarkers of cardiovascular diseases: an umbrella review of systematic reviews and meta-analyses. Nutr Res. 2019;61:1–12.
   PubMed Web of Science ®Google Scholar
• Moser MA, Chun OK. Vitamin C and heart health: a review based on findings from epidemiologic studies. Int J Mol Sci. 2016;17(8).
   PubMed Web of Science ®Google Scholar
• Putzu A, Daems AM, Lopez-Delgado JC, et al. The effect of vitamin C on clinical outcome in critically ill patients: a systematic review with meta-analysis of randomized controlled trials. Crit Care Med. 2019;47(6):774–783.
   PubMed Web of Science ®Google Scholar
• Rössig L, Hoffmann J, Hugel B, et al. Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation. 2001;104(18):2182–2187.
   PubMed Web of Science ®Google Scholar
• Martin A, Frei B. Both intracellular and extracellular vitamin C inhibitatherogenic modification of LDL by human vascular endothelial cells. Arterioscler Thromb Vasc Biol. 1997;17(8):1583–1590.
   PubMed Web of Science ®Google Scholar
• Ting HH, Timimi FK, Haley EA, et al. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 1997;95(12):2617–2622.
   PubMed Web of Science ®Google Scholar
• Heller R, Unbehaun A, Schellenberg B, et al. L-Ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem. 2001;276(1):40–47.
   PubMed Web of Science ®Google Scholar
• Nijveldt RJ, van Nood E, van Hoorn DE, et al. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr. 2001;74(4):418–425.
   PubMed Web of Science ®Google Scholar
• Freedman JE, Parker C 3rd, Li L, et al. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation. 2001;103(23):2792–2798.
   PubMed Web of Science ®Google Scholar
• Sudano I, Flammer AJ, Roas S, et al. Cocoa, blood pressure, and vascular function. Curr Hypertens Rep. 2012;14(4):279–284.
   PubMed Web of Science ®Google Scholar
• Larsson SC. Coffee, tea, and cocoa and risk of stroke. Stroke. 2014;45(1):309–314.
   PubMed Web of Science ®Google Scholar
• Giordano P, Scicchitano P, Locorotondo M, et al. Carotenoids and cardiovascular risk. Curr Pharm Des. 2012;18(34):5577–5589.
   PubMed Web of Science ®Google Scholar
• Rissanen TH, Voutilainen S, Nyyssönen K, et al. Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr. 2001;85(6):749–754.
   PubMed Web of Science ®Google Scholar
• Bahonar A, Saadatnia M, Khorvash F, et al. Carotenoids as potential antioxidant agents in stroke prevention: a systematic review. Int J Prev Med. 2017;8:70.
   PubMed Web of Science ®Google Scholar
• Oude Griep LM, Verschuren WM, Kromhout D, et al. Variety in fruit and vegetable consumption and 10-year incidence of CHD and stroke. Public Health Nutr. 2012;15(12):2280–2286.
   PubMed Web of Science ®Google Scholar
• Palozza P. Prooxidant actions of carotenoids in biologic systems. Nutr Rev. 1998;56(9):257–265.
   PubMed Web of Science ®Google Scholar
• Faulks RM, Hart DJ, Scott KJ, et al. Changes in plasma carotenoid and vitamin E profile during supplementation with oil palm fruit carotenoids. J Lab Clin Med. 1998;132(6):507–511.
   PubMed Web of Science ®Google Scholar
• Littarru GP, Tiano L. Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Mol Biotechnol. 2007;37(1):31–37.
   PubMed Web of Science ®Google Scholar
• Singh JA, Yu S. Allopurinol and the risk of stroke in older adults receiving medicare. BMC Neurol. 2016;16(1):164.
   PubMedGoogle Scholar
• Zhang Q, Lan Y, He XF, et al. Allopurinol protects against ischemic insults in a mouse model of cortical microinfarction. Brain Res. 2015;1622:361–367.
   PubMed Web of Science ®Google Scholar
• Dawson J, Quinn TJ, Harrow C, et al. The effect of allopurinol on the cerebral vasculature of patients with subcortical stroke; a randomized trial. Br J Clin Pharmacol. 2009;68(5):662–668.
   PubMed Web of Science ®Google Scholar
• Britnell SR, Chillari KA, Brown JN. The role of xanthine oxidase inhibitors in patients with history of stroke: a systematic review. Curr Vasc Pharmacol. 2018;16(6):583–588.
   PubMed Web of Science ®Google Scholar
• White WB, Saag KG, Becker MA, et al. Cardiovascular safety of febuxostat or allopurinol in patients with gout. N Engl J Med. 2018;378(13):1200–1210.
   PubMed Web of Science ®Google Scholar
• Kojima S, Matsui K, Ogawa H, et al. Rationale, design, and baseline characteristics of a study to evaluate the effect of febuxostat in preventing cerebral, cardiovascular, and renal events in patients with hyperuricemia. J Cardiol. 2017;69(1):169–175.
   PubMed Web of Science ®Google Scholar
• Pluta RM, Rak R, Wink DA, et al. Effects of nitric oxide on reactive oxygen species production and infarction size after brain reperfusion injury. Neurosurgery. 2001;48(4):884–892; discussion 892.
   PubMed Web of Science ®Google Scholar
• Ehlert A, Schmidt C, Wölfer J, et al. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study. J Neurosurg. 2016;124(1):51–58.
   PubMed Web of Science ®Google Scholar